Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms.

D Porte1, S E Kahn

  • 1University of California and Veterans Affairs San Diego Health Care System 92161, USA. dporte@ucsd.edu

Diabetes
|March 29, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring residual risk for diabetes and microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS).

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Regulation of food intake and body weight by insulin.

Diabetologia·2016
Same author

Peptides and the control of meal size.

Diabetologia·2016
Same author

Steroid Sex Hormones, Sex Hormone-Binding Globulin, and Diabetes Incidence in the Diabetes Prevention Program.

The Journal of clinical endocrinology and metabolism·2015
Same author

The duodenal glucose load impacts the oral disposition index in healthy subjects.

Diabetic medicine : a journal of the British Diabetic Association·2015
Same author

Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype.

International journal of obesity (2005)·2015

Type 2 diabetes involves progressive beta-cell dysfunction, leading to insulin deficiency. Islet amyloid polypeptide (IAPP) deposits contribute to this loss, worsening hyperglycemia despite treatments.

Area of Science:

  • Endocrinology and Metabolism
  • Cell Biology
  • Diabetes Research

Background:

  • Type 2 diabetes is marked by gradual beta-cell function decline.
  • This loss involves impaired insulin secretion phases and glucose potentiation.
  • Observed beta-cell loss exceeds that explained by cell death alone.

Purpose of the Study:

  • To review the role of amyloid deposition in beta-cell dysfunction and failure.
  • To explore the association between islet amyloid polypeptide (IAPP) and hyperproinsulinemia.
  • To hypothesize the timing and mechanism of IAPP amyloid formation in diabetes progression.

Main Methods:

  • Review of existing literature on beta-cell function in type 2 diabetes.
  • Analysis of studies on islet amyloid deposits and their functional impact.

Related Experiment Videos

  • Examination of data from IAPP transgenic mouse models of diabetes.

    • Main Results:

    • Amyloid deposits in islets are linked to disproportionate hyperproinsulinemia.
    • Amyloid fibril formation appears to impair beta-cell function early.
    • IAPP transgenic mice develop islet amyloid deposits and hyperglycemia.

    Conclusions:

    • Amyloid fibril formation is implicated in early functional impairment and late beta-cell failure.
    • The process of amyloid deposition contributes to progressive hyperglycemia in type 2 diabetes.
    • Targeting amyloid formation may offer new therapeutic strategies for type 2 diabetes.